Inicio>>Signaling Pathways>> GPCR/G protein>> GHSR>>TM-N1324

TM-N1324 (Synonyms: Compound 1324, Cpd1324)

Catalog No.GC31074

TM-N1324 es un agonista del receptor 39 acoplado a proteÍna G (GPR39) con CE50 de 9 nM/5 nM en presencia de Zn2+ y 280 nM/180 nM en ausencia de Zn2+ para GPR39 humano/murino.

Products are for research use only. Not for human use. We do not sell to patients.

TM-N1324 Chemical Structure

Cas No.: 1144477-35-9

Tamaño Precio Disponibilidad Cantidad
10mM (in 1mL DMSO)
98,00 $
Disponible
1mg
46,00 $
Disponible
5mg
111,00 $
Disponible
10mg
213,00 $
Disponible
50mg
853,00 $
Disponible
100mg
1.622,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

TM-N1324 is an agonist of G-Protein-Coupled Receptor 39 (GPR39) with EC50s of 9 nM/5 nM in the presence of Zn2+, and 280 nM/180 nM in the absence of Zn2+ for human/murine GPR39.

TM-N1324 activates human GPR39 with high efficacy and potencies of 280 nM and 9 nM in the absence and presence of Zn2+, respectively. TM-N1324 has similar potencies on murine GPR39, 180 nM and 5 nM. TM-N1324 is also found to have promising in vitro ADME properties. TM-N1324 has reasonably good aqueous solubility (65 μM at pH 7.0). Measurements of somatostatin confirms that the GPR39 agonist TM-N1324 increases somatostatin release by 53%[1].

[1]. Frimurer TM, et al. Model-Based Discovery of Synthetic Agonists for the Zn2+-Sensing G-Protein-Coupled Receptor 39 (GPR39) Reveals Novel Biological Functions. J Med Chem. 2017 Feb 9;60(3):886-898.

Reseñas

Review for TM-N1324

Average Rating: 5 ★★★★★ (Based on Reviews and 11 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for TM-N1324

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.